https://www.selleckchem.com/products/pt2385.html
rial); rehabilitation therapy in older acute heart failure patients (REHAB-HF trial); and aspirin dosing a patient-centric trial assessing benefits and long-term effectiveness (ADAPTABLE trial). In addition, we review the results of the American College of Cardiology Global Heart Attack Initiative (GHATI). Finally, we discuss the secondary analysis of the STRENGTH trial assessing the association of achieved levels of omega-3 fatty acid levels and major cardiovascular outcomes. The studies presented at the virtual American College of Card
Like
Comment
Share
